Biovail profit dips but hunt for deals continues |
Reuters - Nov 5, 2009 |
Biovail Corp (BVF.TO) (BVF.N) reported a lower quarterly profit on Thursday, hurt by research and development costs and restructuring charges.
But Canada's biggest publicly traded pharmaceutical company said that would not slow its hunt for acquisitions as it continues its efforts to transform itself into a company focused on treatments for central nervous system disorders.
Since announcing the new focus last year, Biovail has struck five acquisition deals and said on Thursday that it is eyeing another 10 to 20 deals of varying sizes and shapes as it sits on a war chest of about $500 million.
Read Full Article from Reuters
- Posted: 2009-11-05 10:58:32
More Stock Investor Place Top Stories |
|
|
|
Stock Investor Place Top Stories Archive |
|
|